Eczema is a chronic hypersensitivity reaction affecting a large number of people worldwide. Usually, the condition is treated using topical corticosteroids and other dry skin remedies such as moisturizers, oils, etc. Moderate-to-severe cases of eczema require treatment with antibiotics, antivirals, or antibodies, depending on the root cause of the condition. Dupilumab is a human monoclonal antibody that has recently gained popularity for treating eczema, particularly atopic dermatitis.
Its specifically targeted immunological effects are responsible for the improved efficacy of the drug. Solve this question to refresh your knowledge of the mechanism of action of dupilumab. Which of the following are the targets of dupilumab while treating patients with eczema? IL-4 and IL-13 IL-5 and IL-4 IL-12 and IL-23 IL-2 and IL-22 ##Disclaimer## The content provided on Docplexus is intended for…
